Showing results (1381-1390 of 1,529) with videos related to

Sort By:
Pageof 153
Bioorganic & Medicinal Chemistry Letters|June 15, 2007
Discovery of 3-aminopiperidines as potent, selective, and orally bioavailable dipeptidyl peptidase IV inhibitorsJason M Cox, Bart Harper, Anthony Mastracchio, et al.
American Journal of Obstetrics and Gynecology|September 1, 2009
Anatomic outcomes of vaginal mesh procedure (Prolift) compared with uterosacral ligament suspension and abdominal sacrocolpopexy for pelvic organ prolapse: a Fellows' Pelvic Research Network studyTatiana V D Sanses, Azin Shahryarinejad, Stephanie Molden, et al.
Bioorganic & Medicinal Chemistry Letters|February 26, 2004
Fluoropyrrolidine amides as dipeptidyl peptidase IV inhibitorsCharles G Caldwell, Ping Chen, Jiafang He, et al.
Bioorganic & Medicinal Chemistry Letters|September 11, 2007
Design, synthesis, and biological evaluation of triazolopiperazine-based beta-amino amides as potent, orally active dipeptidyl peptidase IV (DPP-4) inhibitorsJennifer E Kowalchick, Barbara Leiting, KellyAnn D Pryor, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|June 18, 2002
Metabolism of a thiazole benzenesulfonamide derivative, a potent and elective agonist of the human beta3-adrenergic receptor, in rats: identification of a novel isethionic acid conjugateWei Tang, Ralph A Stearns, Randall R Miller, et al.
Bioorganic & Medicinal Chemistry Letters|August 25, 2004
Substituted piperazines as novel dipeptidyl peptidase IV inhibitorsLinda L Brockunier, Jiafang He, Lawrence F Colwell, et al.
BMC Biochemistry|April 6, 2010
Globin-like proteins in Caenorhabditis elegans: in vivo localization, ligand binding and structural propertiesEva Geuens, David Hoogewijs, Marco Nardini, et al.
Nature Communications|September 7, 2021
Spectroscopic glimpses of the transition state of ATP hydrolysis trapped in a bacterial DnaB helicaseAlexander A Malär, Nino Wili, Laura A Völker, et al.
Bioorganic & Medicinal Chemistry Letters|April 17, 2007
Triazolopiperazine-amides as dipeptidyl peptidase IV inhibitors: close analogs of JANUVIA (sitagliptin phosphate)Dooseop Kim, Jennifer E Kowalchick, Scott D Edmondson, et al.
Stroke|June 15, 2022
Patient-Centered Outcomes in a Randomized Trial Investigating a Multimodal Prevention Program After Transient Ischemic Attack or Minor Stroke: The INSPiRE-TMS TrialThomas Ihl, Michael Ahmadi, Inga Laumeier, et al.
Pageof 153